Annual Short Term Debt
$21.99 M
-$14.75 M-40.15%
31 December 2023
Summary:
Akebia Therapeutics annual short term debt is currently $21.99 million, with the most recent change of -$14.75 million (-40.15%) on 31 December 2023. During the last 3 years, it has risen by +$16.70 million (+316.02%). AKBA annual short term debt is now -78.51% below its all-time high of $102.34 million, reached on 31 December 2021.AKBA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$5.29 M
+$110.00 K+2.12%
30 September 2024
Summary:
Akebia Therapeutics quarterly short term debt is currently $5.29 million, with the most recent change of +$110.00 thousand (+2.12%) on 30 September 2024. Over the past year, it has dropped by -$7.57 million (-58.88%). AKBA quarterly short term debt is now -94.85% below its all-time high of $102.61 million, reached on 31 March 2022.AKBA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.1% | -58.9% |
| 3 y3 years | +316.0% | -7.6% |
| 5 y5 years | +46.6% | +8.3% |
AKBA Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.5% | +316.0% | -94.8% | +4.3% |
| 5 y | 5 years | -78.5% | +340.8% | -94.8% | +8.3% |
| alltime | all time | -78.5% | +340.8% | -94.8% | >+9999.0% |
Akebia Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.29 M(+2.1%) |
| June 2024 | - | $5.18 M(+2.1%) |
| Mar 2024 | - | $5.07 M(-76.9%) |
| Dec 2023 | $21.99 M(-40.2%) | $21.99 M(+71.0%) |
| Sept 2023 | - | $12.86 M(-55.3%) |
| June 2023 | - | $28.76 M(-1.4%) |
| Mar 2023 | - | $29.16 M(-20.6%) |
| Dec 2022 | $36.74 M(-64.1%) | $36.74 M(-47.7%) |
| Sept 2022 | - | $70.21 M(-31.6%) |
| June 2022 | - | $102.58 M(-0.0%) |
| Mar 2022 | - | $102.61 M(+0.3%) |
| Dec 2021 | $102.34 M | $102.34 M(+1688.3%) |
| Sept 2021 | - | $5.72 M(+2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $5.58 M(+2.7%) |
| Mar 2021 | - | $5.43 M(+2.7%) |
| Dec 2020 | $5.29 M(+6.0%) | $5.29 M(-0.6%) |
| Sept 2020 | - | $5.32 M(+2.1%) |
| June 2020 | - | $5.21 M(+2.2%) |
| Mar 2020 | - | $5.10 M(+2.1%) |
| Dec 2019 | $4.99 M(-66.7%) | $4.99 M(+2.1%) |
| Sept 2019 | - | $4.88 M(+2.2%) |
| June 2019 | - | $4.78 M(+2.2%) |
| Mar 2019 | - | $4.68 M(-68.8%) |
| Dec 2018 | $15.00 M | $15.00 M(>+9900.0%) |
| June 2014 | - | $3900.00(0.0%) |
| Mar 2014 | - | $3900.00 |
FAQ
- What is Akebia Therapeutics annual short term debt?
- What is the all time high annual short term debt for Akebia Therapeutics?
- What is Akebia Therapeutics annual short term debt year-on-year change?
- What is Akebia Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly short term debt year-on-year change?
What is Akebia Therapeutics annual short term debt?
The current annual short term debt of AKBA is $21.99 M
What is the all time high annual short term debt for Akebia Therapeutics?
Akebia Therapeutics all-time high annual short term debt is $102.34 M
What is Akebia Therapeutics annual short term debt year-on-year change?
Over the past year, AKBA annual short term debt has changed by -$14.75 M (-40.15%)
What is Akebia Therapeutics quarterly short term debt?
The current quarterly short term debt of AKBA is $5.29 M
What is the all time high quarterly short term debt for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly short term debt is $102.61 M
What is Akebia Therapeutics quarterly short term debt year-on-year change?
Over the past year, AKBA quarterly short term debt has changed by -$7.57 M (-58.88%)